ihuman institute

One Receptor, Two Disparate Binding Sites

The unusual dual binding sites of the GPCR P2Y1R could lead to new blood clotting drugs.

Amgen China R&D Center To Open On ShanghaiTech Campus

Amgen will open a China research and development center at ShanghaiTech University in 2014.